,
Department of Pathology, Faculty of Medicine, University of Sarajevo , Sarajevo , Bosnia and Herzegovina
Cantonal Hospital Zenica , Zenica , Bosnia and Herzegovina
Department of Pathology, Faculty of Medicine, University of Sarajevo , Sarajevo , Bosnia and Herzegovina
Department of Pathology, Faculty of Medicine, University of Sarajevo , Sarajevo , Bosnia and Herzegovina
Department of Pathology, Faculty of Medicine, University of Sarajevo , Sarajevo , Bosnia and Herzegovina
Department of Pathology, Faculty of Medicine, University of Sarajevo , Sarajevo , Bosnia and Herzegovina
Department of Pathology, Faculty of Medicine, University of Sarajevo , Sarajevo , Bosnia and Herzegovina
Aim to investigate the prevalence of cervical cytology abnormalities over five years and to correlate it with patient’s age and presence/absence of HPV infection.
Methods Pap findings of 614 women with documented cervical abnormalities and Pap findings of HPV-positive women (regardless of whether the Pap test showed an intraepithelial abnormality) were included in this study.
Results The majority of women included in the study (36.5%) were aged 30-39 years. The most common abnormalities included atypical squamous cells-ASC (47.4%) and low-grade intraepithelial lesions (LSIL)-15.1%. Out of 614 women, 270 (43.9%) were positive for HPV. HR HPV positivity was found in 256 (41.7%). The proportion of HPV infection positivity decreases with age, especially in the two oldest age groups (women older than 60), p=0.03. The analysis showed a higher ratio of Pap smear abnormalities in groups of patients older than 40 years of age (p=0.02). The youngest age group (patients younger than 20 years of age) showed no other lesions than ASC, while women younger than 40 had no SCC on Pap smear. (p<0.01). Out of 256 HR HPV- positive women 42.2% (n=108) showed Pap abnormalities. HR HPV-positive women more commonly had HSIL lesions, but without statistical significance (p>0.05).
Conclusion The results obtained contribute to the knowledge about HPV prevalence and the incidence of squamous cell abnormalities and confirm the necessity for further implementation of HPV vaccination and organized cervical cancer screening program on national level.
Keywords: cervical dysplasia, Pap smear, screening
Conceptualization, N.Č.; Data curation, N.Č., A.B., E.M., M.B. and M.D.; Formal Analysis, N.Č. and A.B.; Methodology, N.Č., E.M., S.K. and E.L.S.; Writing – original draft, N.Č. and E.M.; Validation, A.B.; Investigation, M.B. and M.D.; Supervision, M.B., M.D., S.K. and E.L.S.; Writing – review & editing, S.K. and E.L.S. All authors have read and agreed to the published version of the manuscript.
No specific funding was received for this study
This work is licensed under a Attribution-NonCommercial-NoDerivatives 4.0 International 
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.